[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"multiple-indications-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:multiple-indications-cancer":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100615635",false,"NCT07295171","HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG","HELP","Inclusion Criteria:\n\n* Age ≥19 years\n* Participants who have received a standard of care \\[18F\\]FDG PET\u002FCT and are willing to undergo a study specific oral \\[18F\\]FDG PET\u002FCT within 2 weeks.\n\nExclusion Criteria:\n\nParticipant Inclusion Criteria\n\n* Age ≥19 years\n* Participants who have received a standard of care \\[18F\\]FDG PET\u002FCT and are willing to undergo a study specific oral \\[18F\\]FDG PET\u002FCT within 2 weeks.\n\nParticipant Exclusion Criteria\n\n* Pregnant or breast-feeding\n* Medically unstable (e.g., acute illness, unstable vital signs)\n* Urinary incontinence\u002Fcatheter.\n* Immobile, frail or vulnerable patients who cannot leave the department and would require an uptake room in any case.\n* Patients whose fasting blood sugar at the SOC PET was \\>11.0 mmol\u002Fl\n* Unable to swallow.\n* Patients with nasogastric tubes, percutaneous gastrostomy or other non-anatomical routes for nutrition.\n* Unable to lie flat for 1h (subset of participants - first 5 participants only).\n* Claustrophobia requiring medication.\n* Undergoing active treatment or assessment of an upper digestive tract tumor (stomach\u002Fesophagus)\n* Unable to provide written consent\n* Patients receiving biguanide anti-hyperglycemic agents (e.g. Metformin).\n* Insulin dependent diabetics.","ALL","19 Years",{"count":18,"type":19},27,"ESTIMATED","INTERVENTIONAL",[22],"NA","Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 individuals who will receive two PET scans - one using delayed oral 18F-FDG imaging and a second regular 18F-FDG. The analysis will focus on establishing a suitable protocol for this administration route while considering patient preference and image quality.",[25,26,27],"Multiple Cancers","Multiple Indications Cancer","Feasibility Studies",[29,30,31,32,33],"Oral FDG","LAFOV","Long-axial Field-of-view Scanner","Quadra","Low-dose Oral Radiopharmaceuticals","RECRUITING","2026-03-26",{"date":37,"type":38},"2026-03-31","ACTUAL",{"date":40,"type":38},"2026-02-18",{"date":42,"type":19},"2027-02-18",{"name":44,"class":45},"British Columbia Cancer Agency","OTHER",""]